The difference in the odds of development of bleomycin pulmonary toxicity in patients with germ cell tumors and Hodgkin’s lymphoma receiving granulocyte colony-stimulating factor alongside bleomycin based regimens: Systematic review and meta-analysis.
Authors: Adarsh Vardhan Tangella, Siddharth Kumar
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e17015
Source:
Full article
Abstract
e17015